PharmiWeb.com - Global Pharma News & Resources

Pharmacy - Press Releases

Date Title Company
19-Dec-2023 New hot-flush treatment VEOZA▼™ (fezolinetant): first-in-class non-hormonal medicine for moderate to severe vasomotor symptoms associated with menopause licensed in Great Britain Astellas Pharma Inc
06-Dec-2023 Rare disease patients are breaking down language and location barriers in a new online community Sciensus
30-Nov-2023 Ardena's new Aseptic Fill-Finish Plant in Ghent receives GMP license Ardena
28-Nov-2023 Charac secures £1m investment from world-class medication platform MedAdvisor to drive its international growth Charac
21-Nov-2023 Immix Biopharma Announces FDA Approval of IND Application for CAR-T NXC-201, Enabling U.S. Patient Dosing Immix Biopharma, Inc.
17-Nov-2023 Contraceptive services to be expanded under Pharmacy First scheme, PAGB response The Department for Health and Social Care (DHSC)
16-Nov-2023 Empowering Chemical Research: Alfa Chemistry Debuts Automated Synthesis Solutions Alfa Chemistry
25-Oct-2023 Samsung Biologics reports third quarter 2023 financial results Samsung Biologics
23-Oct-2023 Samsung Biologics and Kurma Partners announce strategic partnership for development and manufacturing of biologics for Kurma’s portfolio companies Samsung Biologics
21-Oct-2023 Maximizing Therapeutic Potential: CD Formulation's Versatile Drug Delivery Systems Advance Pharmacokinetics and Pharmacodynamics CD Formulation
20-Oct-2023 Andelyn Biosciences and Purespring Therapeutics Partner to Manufacture Novel Gene Therapies for Kidney Diseases Andelyn
20-Oct-2023 Alfa Chemistry Newly Launches IVD Products for Laboratory Use Alfa Chemistry
20-Oct-2023 CD Formulation’s Physical Parameter Determination: A Crucial Step in Pharmaceutical Analysis and Testing CD Formulation
19-Oct-2023 Securing the Integrity of Microneedle Structure Design and Optimization: CD Formulation's Performance Testing Approach CD Formulation
16-Oct-2023 Teva Phase IV UNITE Study Shows AJOVY® (fremanezumab) Reduced Migraine Attacks and Depression Symptoms in Migraine Sufferers with Major Depressive Disorder Teva Pharmaceuticals
11-Oct-2023 THE MOST TECHNOLOGICALLY ENABLED DISTRIBUTION BUSINESS LAUNCHES NEW MEDICAL DIVISION AT LAB INNOVATIONS 2023 The Delivery Group
10-Oct-2023 LYNPARZA (OLAPARIB) ACCEPTED FOR USE IN SCOTLAND AS ADJUVANT TREATMENT FOR PATIENTS WITH GERMLINE BRCA-MUTATED HER2-NEGATIVE HIGH RISK EARLY BREAST CANCER AstraZeneca
06-Oct-2023 ACROMETA's Life Science Incubator (LSI) Signs Agreement with Ho Bee Land subsidiary to operate Co-Working Laboratory AcroMeta Group Limited
18-Sep-2023 CD Formulation Demonstrates Expertise in CAR-T and CAR-NK Cell Development for Drug Delivery Systems CD Formulation
15-Sep-2023 CD Formulation Provides Customization and Development Options for Shaped Healthcare Products CD Formulation